Abstract
This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 1131-1137 |
| Number of pages | 7 |
| Journal | Current Medical Research and Opinion |
| Volume | 21 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 1 2005 |
| Externally published | Yes |
Fingerprint
Keywords
- Cataract treatment strategy
- Cystoid macular edema
- Nonsteroidal antiinflammatory drugs
ASJC Scopus subject areas
- Medicine(all)
Cite this
Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. / O'Brien, Terrence.
In: Current Medical Research and Opinion, Vol. 21, No. 7, 01.07.2005, p. 1131-1137.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care
AU - O'Brien, Terrence
PY - 2005/7/1
Y1 - 2005/7/1
N2 - This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.
AB - This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal antiinflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro-drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.
KW - Cataract treatment strategy
KW - Cystoid macular edema
KW - Nonsteroidal antiinflammatory drugs
UR - http://www.scopus.com/inward/record.url?scp=22744455811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=22744455811&partnerID=8YFLogxK
U2 - 10.1185/030079905X50651
DO - 10.1185/030079905X50651
M3 - Article
VL - 21
SP - 1131
EP - 1137
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
SN - 0300-7995
IS - 7
ER -